Funding · Company

ECM Therapeutics, Inc.

Warrendale, PABiotech & Pharma

ECM Therapeutics, Inc. of Warrendale, PA has disclosed $35M across 1 Form D offering filed with the SEC on Oct 10, 2025.

$35M
Total disclosed
1
Form D offering

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$35M
Form D · Oct 10, 2025 ↗
Q4 2025 · 4 amendments, first filed Jul 30, 2021 · target $40M
Filing details
HeadquartersWarrendale, PAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001743104Offerings on file1
Links

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →